8-K//Current report
Aspire Biopharma Holdings, Inc. 8-K
Accession 0001493152-25-022580
$ASBPCIK 0001847345operating
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:00 AM ET
Size
643.9 KB
Accession
0001493152-25-022580
Documents
- 8-Kform8-k.htmPrimary
8-K
- EX-10.1ex10-1.htm
EX-10.1
- EX-101.SCHasbp-20251111.xsd
XBRL SCHEMA FILE
- EX-101.DEFasbp-20251111_def.xml
XBRL DEFINITION FILE
- EX-101.LABasbp-20251111_lab.xml
XBRL LABEL FILE
- EX-101.PREasbp-20251111_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001493152-25-022580-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLform8-k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Aspire Biopharma Holdings, Inc.
CIK 0001847345
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001847345
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 8:00 AM ET
- Size
- 643.9 KB